No Detail Found!

Comparison of Frequency of Rapid Virological Response in Patients of Hepatitis C being Treated with 25-OH Vitamin D along with Sofosbuvir/Ribavirin with Those Treated with Sofosbuvir/Ribavirin only

Author(s)
JAMILA KHAN Department of Gastroenterology, POF Hospital,Wah Cantt, Pakistan
NOREEN ADIL Department of Gastroenterology, POF Hospital, Wah Cantt, Pakistan
AQSA NASEER Department of Gastroenterology, Holy Family Hospital, Rawalpindi, Pakistan
MUHAMMAD ASIF THQ Hospital, Banda Daud Shah, Shakardara, Pakistan
ASMA SABIR Department of Pulmonology, POF Hospital, Wah Cantt, Pakistan
SADIA FATIMA Department of General Medicine, POF Hospital, Wah Cantt, Pakistan
Abstract
Background: Hepatitis C is the leading cause of liver damage that lead to death if left untreated. Sofosbuvir has recently attained enormous success due to high rate of virological response. Recent studies have shown that addition of vitamin D to antiviral therapy improves the efficacy of treatment in patients with Hepatitis C. Objective: To compare the frequency of virological response in hepatitis C patients treated with vitamin D along with sofosbuvir plus ribavirin to those treated with sofosbuvir plus ribavirin only Study Design: Randomized-controlled-trial Place and Duration of Study: Department of Medicine, Pak Emirates Military Hospital, Rawalpindi from 1st November 2017 to 30th April 2018. Methodology: One hundred patients of chronic hepatitis C were included. Patients were randomly divided into two groups; group A receiving vitamin D along with sofosbuvir plus ribavirin and group B receiving sofosbuvir plus ribavirin therapy only. Patients were treated for 6 months and their RVR was monitored. Results: The mean age of patients in combination group was 39.0±12.92 years and in control group were 36.66±13.80years. After 4 weeks, RVR (no HCV RNA detected on PCR) was achieved in 31 (62%) cases in combination group while in 19 (38%) cases there was still HCV RNA present. In control group, RVR could be achieved in 18 (36%) cases while in 32 (64%) cases, RVR could not be achieved. The difference was significant between both groups (p<0.05). Conclusion: The addition of vitamin D can help in achieving RVR in >50% cases within 4 weeks. So addition of vitamin D in standard therapy may help to improve the quality of treatment.
Publication Details
Page(s) 342-343
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
Hepatitis C, ribavirin, Sofosbuvir, rapid virological response, 25-OH vitamin D
References
Vosoghinia H,Esmaeilzadeh A,Ganji A,Hosseini SM,Jamehdar SA,Salehi M .2016 .Vitamin D in standard HCV regimen (PEGinterferon plus ribavirin), its effect on the early virologic response rate: a clinical trial. Razavi Int J Med, 4(2) : .
Loftfield E,O'Brien TR,Pfeiffer RM,Howell CD,Horst R,ProkuninaOlsson L,VIRAHEP-C Trials L .2016 .Vitamin D status and virologic response to HCV therapy in the HALT-C and. , 11(11) : e0166036.
Ali SA,Donahue RM,Qureshi H,Vermund SH .2009 .Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infec Dis, 13(1) : 9-19.
.2016 .Sofosbuvir treatment and hepatitis C virus infection. World J Hepatol, 8(3) : 183.
Feldman M,Friedman LS,Brandt LJ,Consult Premium Edition-Enhanced Online Expert .2010 .Sleisenger and Fordtran's Gastrointestinal and Liver Disease. , : .
Mahon BD,Wittke A,Weaver V,Cantorna MT .2003 .The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cellular Biochem, 89(5) : 922-32.
Abu-Mouch S,Fireman Z,Jarchovsky J,Zeina AR,Assy N. .2011 .Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. WJG, 17(47) : 5184.
Arteh J,Narra S,Nair S. .2010 .Prevalence of vitamin D deficiency in chronic liver disease. Digestive Dis Sci, 55(9) : 2624-8.
Petta S,Camma C,Scazzone C,Tripodo C,Di Marco V,Bono A .2010 .Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C. Hepatology, 51(4) : 1158-67.
Southern PB,El Sayed P,Fenton L,Forrester K,Moreea S. Influence Of Vitamin D Supplementation K .2010 .On Outcome In The Treatment Of Chronic Hepatitis C. Hepatology, 52 : 807A-8.
Thanapirom K,Suksawatamnuay S,Sukeepaisarnjaroen W,Tangkijvanich P,Treeprasertsuk S,Thaimai P .2017 .Vitamin Drelated gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. BMC Gastroenterol, 17(1) : 54.
.2014 .American Association for the Study of Liver Diseases, Infectious Diseases Society of America. Recommendations for testing, managing. , : .
JM Pawlotsky .2014 .New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology, 146(5) : 1176-92.
Sabry D,Al-Ghussein MA,Hamdy G,Abul-Fotouh A,Motawi T,El Kazaz AY . .Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients. , : .
.2015 .. Therapeutics Clin Risk Management, 11 : 279.
Vitamin .2015 .D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. WJG, 21(18) : 5647.
J Hepatol .2014 .. , 61(6) : 1247-52.
Jiménez-Sousa MA,Rallón N,Berenguer J,Pineda-Tenor D,López JC,Soriano V .2015 .TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients. J Clin Virol, 65 : 62-7.
Luo Y-q,Xiang C .2014 .Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis. J Zhejiang Univ Sci B, 15(10) : 900-6.
0

Citations

0

Downloads

71

Views